![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 1Neoral/Sandimmun(e)
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 393
2019 Revenue in Millions : 419
Growth (%) : -6
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 368
2020 Revenue in Millions : 393
Growth (%) : -6
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 282
2015 Revenue in Millions : 365
Growth (%) : -23
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 236
2016 Revenue in Millions : 282
Growth (%) : -16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 463
2017 Revenue in Millions : 488
Growth (%) : -5%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 419
2018 Revenue in Millions : 463
Growth (%) : -10
LOOKING FOR A SUPPLIER?